ANIP logo

ANI Pharmaceuticals, Inc. (ANIP) Cash From Operations

Annual CFO:

$64.02M-$54.94M(-46.19%)
December 31, 2024

Summary

  • As of today, ANIP annual cash from operations is $64.02 million, with the most recent change of -$54.94 million (-46.19%) on December 31, 2024.
  • During the last 3 years, ANIP annual cash from operations has risen by +$60.70 million (+1827.06%).
  • ANIP annual cash from operations is now -46.19% below its all-time high of $118.96 million, reached on December 31, 2023.

Performance

ANIP Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPcash flow metrics

Quarterly CFO:

$44.05M-$31.76M(-41.89%)
September 30, 2025

Summary

  • As of today, ANIP quarterly cash from operations is $44.05 million, with the most recent change of -$31.76 million (-41.89%) on September 30, 2025.
  • Over the past year, ANIP quarterly cash from operations has increased by +$31.58 million (+253.17%).
  • ANIP quarterly cash from operations is now -41.89% below its all-time high of $75.81 million, reached on June 30, 2025.

Performance

ANIP Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPcash flow metrics

TTM CFO:

$170.72M+$31.58M(+22.70%)
September 30, 2025

Summary

  • As of today, ANIP TTM cash from operations is $170.72 million, with the most recent change of +$31.58 million (+22.70%) on September 30, 2025.
  • Over the past year, ANIP TTM cash from operations has increased by +$77.82 million (+83.77%).
  • ANIP TTM cash from operations is now at all-time high.

Performance

ANIP TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ANIP Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-46.2%+253.2%+83.8%
3Y3 Years+1827.1%+1116.0%+537.9%
5Y5 Years+40.3%+2829.6%+562.2%

ANIP Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-46.2%+305.2%-41.9%+1101.3%at high+537.9%
5Y5-Year-46.2%+305.2%-41.9%+332.6%at high+455.6%
All-TimeAll-Time-46.2%+233.7%-41.9%+332.6%at high+433.8%

ANIP Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
$44.05M(-41.9%)
$170.72M(+22.7%)
Jun 2025
-
$75.81M(+116.7%)
$139.14M(+72.3%)
Mar 2025
-
$34.99M(+120.6%)
$80.74M(+26.1%)
Dec 2024
$64.02M(-46.2%)
$15.86M(+27.1%)
$64.02M(-31.1%)
Sep 2024
-
$12.47M(-28.4%)
$92.90M(-17.5%)
Jun 2024
-
$17.41M(-4.7%)
$112.59M(-2.8%)
Mar 2024
-
$18.27M(-59.2%)
$115.80M(-2.7%)
Dec 2023
$118.96M(+481.2%)
$44.74M(+39.1%)
$118.96M(+70.4%)
Sep 2023
-
$32.17M(+56.0%)
$69.82M(+69.2%)
Jun 2023
-
$20.63M(-3.7%)
$41.27M(+350.4%)
Mar 2023
-
$21.42M(+586.9%)
$9.16M(+129.4%)
Dec 2022
-$31.20M(-1039.3%)
-$4.40M(-221.4%)
-$31.20M(+20.0%)
Sep 2022
-
$3.62M(+131.5%)
-$38.99M(+18.8%)
Jun 2022
-
-$11.48M(+39.4%)
-$48.01M(-32.3%)
Mar 2022
-
-$18.94M(-55.5%)
-$36.29M(-1192.4%)
Dec 2021
$3.32M(-78.2%)
-$12.19M(-125.6%)
$3.32M(-66.1%)
Sep 2021
-
-$5.40M(-2341.5%)
$9.80M(-27.9%)
Jun 2021
-
$241.00K(-98.8%)
$13.59M(-60.3%)
Mar 2021
-
$20.67M(+462.0%)
$34.23M(+124.2%)
Dec 2020
$15.27M(-66.5%)
-$5.71M(-253.7%)
$15.27M(-40.8%)
Sep 2020
-
-$1.61M(-107.7%)
$25.78M(-47.6%)
Jun 2020
-
$20.88M(+1121.1%)
$49.19M(+48.8%)
Mar 2020
-
$1.71M(-64.4%)
$33.05M(-27.6%)
Dec 2019
$45.63M(-32.0%)
$4.80M(-78.0%)
$45.63M(-31.5%)
Sep 2019
-
$21.79M(+359.4%)
$66.64M(+25.7%)
Jun 2019
-
$4.74M(-66.8%)
$53.01M(-6.8%)
Mar 2019
-
$14.29M(-44.6%)
$56.86M(-13.2%)
Dec 2018
$67.07M(+70.2%)
$25.81M(+216.1%)
$65.50M(+18.0%)
Sep 2018
-
$8.17M(-5.0%)
$55.49M(-13.8%)
Jun 2018
-
$8.59M(-62.5%)
$64.41M(+15.4%)
Mar 2018
-
$22.93M(+45.1%)
$55.82M(+41.6%)
Dec 2017
$39.42M(+43.5%)
$15.80M(-7.5%)
$39.42M(+9.5%)
Sep 2017
-
$17.08M(>+9900.0%)
$35.99M(+80.0%)
Jun 2017
-
$1000.00(-100.0%)
$19.99M(-13.2%)
Mar 2017
-
$6.53M(-47.2%)
$23.03M(-16.2%)
Dec 2016
$27.47M(+59.1%)
$12.38M(+1041.7%)
$27.47M(+38.8%)
Sep 2016
-
$1.08M(-64.4%)
$19.80M(-31.6%)
Jun 2016
-
$3.04M(-72.3%)
$28.95M(+6.8%)
Mar 2016
-
$10.97M(+133.3%)
$27.11M(+57.0%)
Dec 2015
$17.26M(-21.6%)
$4.70M(-54.1%)
$17.26M(-25.9%)
Sep 2015
-
$10.24M(+748.8%)
$23.30M(+35.3%)
Jun 2015
-
$1.21M(+7.7%)
$17.23M(-4.2%)
Mar 2015
-
$1.12M(-89.6%)
$17.97M(-18.4%)
Dec 2014
$22.03M(+501.8%)
$10.74M(+158.3%)
$22.03M(+161.4%)
Sep 2014
-
$4.16M(+112.8%)
$8.43M(+219.6%)
Jun 2014
-
$1.95M(-62.3%)
$2.64M(-31.3%)
Mar 2014
-
$5.18M(+280.8%)
$3.84M(+170.0%)
Dec 2013
-$5.48M(+78.3%)
-$2.86M(-75.6%)
-$5.48M(+5.2%)
Sep 2013
-
-$1.63M(-151.7%)
-$5.78M(+49.9%)
Jun 2013
-
$3.16M(+176.2%)
-$11.53M(+46.9%)
Mar 2013
-
-$4.15M(-31.0%)
-$21.74M(+14.0%)
Dec 2012
-$25.28M
-$3.16M(+57.1%)
-$25.28M(+23.5%)
Sep 2012
-
-$7.38M(-4.8%)
-$33.04M(+13.6%)
DateAnnualQuarterlyTTM
Jun 2012
-
-$7.05M(+8.4%)
-$38.24M(+15.2%)
Mar 2012
-
-$7.69M(+29.6%)
-$45.09M(+5.8%)
Dec 2011
-$47.87M(-19.4%)
-$10.93M(+13.2%)
-$47.87M(+6.4%)
Sep 2011
-
-$12.58M(+9.4%)
-$51.15M(-3.5%)
Jun 2011
-
-$13.89M(-32.6%)
-$49.42M(-11.3%)
Mar 2011
-
-$10.47M(+26.3%)
-$44.41M(-10.8%)
Dec 2010
-$40.10M(-117.6%)
-$14.20M(-30.9%)
-$40.10M(-25.2%)
Sep 2010
-
-$10.85M(-22.2%)
-$32.03M(-28.6%)
Jun 2010
-
-$8.88M(-44.1%)
-$24.91M(-23.7%)
Mar 2010
-
-$6.16M(-0.4%)
-$20.13M(-9.2%)
Dec 2009
-$18.43M(-18.6%)
-$6.14M(-64.6%)
-$18.43M(-24.9%)
Sep 2009
-
-$3.73M(+9.2%)
-$14.75M(+13.0%)
Jun 2009
-
-$4.11M(+7.9%)
-$16.96M(+3.3%)
Mar 2009
-
-$4.46M(-81.4%)
-$17.54M(-12.9%)
Dec 2008
-$15.54M(-2199.4%)
-$2.46M(+58.6%)
-$15.54M(-31.9%)
Sep 2008
-
-$5.93M(-26.7%)
-$11.78M(-48.7%)
Jun 2008
-
-$4.68M(-90.4%)
-$7.92M(-50.1%)
Mar 2008
-
-$2.46M(-289.8%)
-$5.28M(-813.0%)
Dec 2007
$740.00K(+114.8%)
$1.30M(+162.6%)
$739.90K(+18.7%)
Sep 2007
-
-$2.07M(-1.6%)
$623.40K(-53.8%)
Jun 2007
-
-$2.04M(-157.4%)
$1.35M(+59.0%)
Mar 2007
-
$3.56M(+201.3%)
$848.30K(+117.0%)
Dec 2006
-$5.00M(+39.8%)
$1.18M(+187.6%)
-$5.00M(+32.0%)
Sep 2006
-
-$1.35M(+47.0%)
-$7.35M(+5.5%)
Jun 2006
-
-$2.54M(-10.9%)
-$7.78M(+2.0%)
Mar 2006
-
-$2.29M(-94.6%)
-$7.94M(+4.3%)
Dec 2005
-$8.30M(+20.5%)
-$1.18M(+33.6%)
-$8.30M(+21.9%)
Sep 2005
-
-$1.77M(+34.4%)
-$10.62M(+8.3%)
Jun 2005
-
-$2.70M(-2.0%)
-$11.58M(-2.9%)
Mar 2005
-
-$2.65M(+24.4%)
-$11.26M(-7.8%)
Dec 2004
-$10.44M(-89.1%)
-$3.50M(-28.3%)
-$10.44M(-25.5%)
Sep 2004
-
-$2.73M(-14.8%)
-$8.32M(-15.8%)
Jun 2004
-
-$2.38M(-29.7%)
-$7.19M(-22.2%)
Mar 2004
-
-$1.83M(-32.6%)
-$5.88M(-6.5%)
Dec 2003
-$5.52M(-39.4%)
-$1.38M(+13.3%)
-$5.52M(-23.9%)
Sep 2003
-
-$1.59M(-48.4%)
-$4.46M(-17.8%)
Jun 2003
-
-$1.07M(+27.0%)
-$3.78M(+8.0%)
Mar 2003
-
-$1.47M(-364.6%)
-$4.11M(-3.8%)
Dec 2002
-$3.96M(-117.3%)
-$316.80K(+65.6%)
-$3.96M(+21.1%)
Sep 2002
-
-$920.30K(+34.4%)
-$5.02M(-63.7%)
Jun 2002
-
-$1.40M(-6.2%)
-$3.07M(-30.0%)
Mar 2002
-
-$1.32M(+3.8%)
-$2.36M(-29.4%)
Dec 2001
-$1.82M(+42.1%)
-$1.37M(-233.1%)
-$1.82M(-37.7%)
Sep 2001
-
$1.03M(+248.3%)
-$1.32M(+52.4%)
Jun 2001
-
-$696.10K(+11.4%)
-$2.79M(+21.1%)
Mar 2001
-
-$785.70K(+10.2%)
-$3.53M(-10.1%)
Dec 2000
-$3.15M(-76.2%)
-$875.10K(-104.3%)
-$3.21M(-18.5%)
Sep 2000
-
-$428.40K(+70.3%)
-$2.71M(-18.8%)
Jun 2000
-
-$1.44M(-212.9%)
-$2.28M(-172.7%)
Mar 2000
-
-$461.20K(-23.2%)
-$835.40K(-123.2%)
Dec 1999
-$1.79M(+41.2%)
-
-
Dec 1999
-
-$374.20K
-$374.20K
Dec 1998
-$3.04M
-
-

FAQ

  • What is ANI Pharmaceuticals, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for ANI Pharmaceuticals, Inc.?
  • What is ANI Pharmaceuticals, Inc. annual cash from operations year-on-year change?
  • What is ANI Pharmaceuticals, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for ANI Pharmaceuticals, Inc.?
  • What is ANI Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
  • What is ANI Pharmaceuticals, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for ANI Pharmaceuticals, Inc.?
  • What is ANI Pharmaceuticals, Inc. TTM cash from operations year-on-year change?

What is ANI Pharmaceuticals, Inc. annual cash from operations?

The current annual cash from operations of ANIP is $64.02M

What is the all-time high annual cash from operations for ANI Pharmaceuticals, Inc.?

ANI Pharmaceuticals, Inc. all-time high annual cash from operations is $118.96M

What is ANI Pharmaceuticals, Inc. annual cash from operations year-on-year change?

Over the past year, ANIP annual cash from operations has changed by -$54.94M (-46.19%)

What is ANI Pharmaceuticals, Inc. quarterly cash from operations?

The current quarterly cash from operations of ANIP is $44.05M

What is the all-time high quarterly cash from operations for ANI Pharmaceuticals, Inc.?

ANI Pharmaceuticals, Inc. all-time high quarterly cash from operations is $75.81M

What is ANI Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?

Over the past year, ANIP quarterly cash from operations has changed by +$31.58M (+253.17%)

What is ANI Pharmaceuticals, Inc. TTM cash from operations?

The current TTM cash from operations of ANIP is $170.72M

What is the all-time high TTM cash from operations for ANI Pharmaceuticals, Inc.?

ANI Pharmaceuticals, Inc. all-time high TTM cash from operations is $170.72M

What is ANI Pharmaceuticals, Inc. TTM cash from operations year-on-year change?

Over the past year, ANIP TTM cash from operations has changed by +$77.82M (+83.77%)
On this page